NEUROVANCE
Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD. Neurovance has been funded in a venture capital investment by Novartis Venture Fund, Venture Investors, Tekla Capital Management, GBS Venture Partners, State of Wisconsin Investment Board (SWIB), and Timothy J. Barberich. It was founded in 2009 and is headquartered in Cambridge, Massachusetts.
NEUROVANCE
Industry:
Biotechnology Clinical Trials Health Care Neuroscience
Founded:
2009-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.neurovance.com
Total Employee:
1+
Status:
Closed
Contact:
(617) 758-0300
Email Addresses:
[email protected]
Total Funding:
31.78 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Symantec Secure Site Citrix NetScaler Register.com DNS Confluence Networks
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Good Start Genetics
Good Start Genetics is a molecular genetic information company that has designed a proprietary tech platform to harness the power of NGS.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Novaseek Research
Novaseek Research is a clinical data analytics and biospecimen sourcing, has developed a clinical data network platform for research.
Prothena
Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
VBI Vaccines
VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Venture Investors
Venture Investors investment in Series A - Neurovance
Venture Investors
Venture Investors investment in Series A - Neurovance
Timothy J. Barberich
Timothy J. Barberich investment in Series A - Neurovance
GBS Ventures
GBS Ventures investment in Series A - Neurovance
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Neurovance
Tekla Capital Management
Tekla Capital Management investment in Series A - Neurovance
H&Q Healthcare Investors
H&Q Healthcare Investors investment in Series A - Neurovance
State of Wisconsin Investment Board
State of Wisconsin Investment Board investment in Series A - Neurovance
State of Wisconsin Investment Board
State of Wisconsin Investment Board investment in Venture Round - Neurovance
GBS Ventures
GBS Ventures investment in Venture Round - Neurovance
Official Site Inspections
http://www.neurovance.com
- Host name: ec2-52-6-21-28.compute-1.amazonaws.com
- IP address: 52.6.21.28
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
